Paul S. Herendeen
- Shareholder represented: FF Hybrid LP, Flat Footed Series LLC-Fund3, GP Recovery Fund LLC, Mason Capital Master Fund, L.P. and Sachem Head LP
- Position: Director
- Type: Proprietary
- First appointment: 09/12/24 by co-option
Mr. Paul S. Herendeen is the Chairman of Endo, Inc. and a Board member of Elanco Animal Health, Inc.
He served as Advisor to the Chairman and Chief Executive Officer at Bausch Health Companies Inc. Prior to that, he was EVP and CFO of Bausch Health. Before joining Bausch Health, he served as EVP and CFO of Zoetis Inc. Prior to that time, Mr. Herendeen served as chief financial officer at Warner Chilcott, a specialty pharmaceuticals company. He rejoined Warner Chilcott after four years as EVP and CFO of MedPointe.
Mr. Herendeen previously worked as a Principal Investor at Dominion Income Management and Cornerstone Partners and spent the early part of his career in banking and public accounting, holding various positions with the investment banking group of Oppenheimer & Company, the capital markets group of Continental Bank Corporation and as a senior auditor with Arthur Andersen & Company.
On the academic side, he holds a bachelor's degree from Boston College and earned a MBA from the University of Virginia's Darden School of Business.